Home  >>  News  >>  Asston Pharmaceuticals IPO: Huge Investor Interest
Asston Pharmaceuticals IPO: Huge Investor Interest

Asston Pharmaceuticals IPO: Huge Investor Interest

Asston Pharmaceuticals has captured significant investor attention with its IPO, achieving an impressive 173.53 times subscription on the final bidding day. During July 9-11, investors subscribed for 27.86 crore equity shares, far exceeding the offer of 16.06 lakh shares. Non-institutional investors led with a staggering 261.67 times subscription, while retail investors subscribed 172.14 times. The Navi Mumbai-based company plans to finalize share allotment by July 14, with trading set to begin on July 16. The IPO aims to raise Rs 27.56 crore for machinery acquisition and working capital, showcasing Asston's growth potential in the pharmaceutical sector.

Trending News